1. Home
  2. RLYB vs KORE Comparison

RLYB vs KORE Comparison

Compare RLYB & KORE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RLYB
  • KORE
  • Stock Information
  • Founded
  • RLYB 2018
  • KORE 2003
  • Country
  • RLYB United States
  • KORE United States
  • Employees
  • RLYB N/A
  • KORE N/A
  • Industry
  • RLYB Biotechnology: Pharmaceutical Preparations
  • KORE Telecommunications Equipment
  • Sector
  • RLYB Health Care
  • KORE Consumer Discretionary
  • Exchange
  • RLYB Nasdaq
  • KORE Nasdaq
  • Market Cap
  • RLYB 14.4M
  • KORE 39.3M
  • IPO Year
  • RLYB 2021
  • KORE N/A
  • Fundamental
  • Price
  • RLYB $0.33
  • KORE $2.30
  • Analyst Decision
  • RLYB Hold
  • KORE Hold
  • Analyst Count
  • RLYB 3
  • KORE 2
  • Target Price
  • RLYB $15.00
  • KORE $2.75
  • AVG Volume (30 Days)
  • RLYB 238.2K
  • KORE 8.1K
  • Earning Date
  • RLYB 08-07-2025
  • KORE 08-14-2025
  • Dividend Yield
  • RLYB N/A
  • KORE N/A
  • EPS Growth
  • RLYB N/A
  • KORE N/A
  • EPS
  • RLYB N/A
  • KORE N/A
  • Revenue
  • RLYB $848,000.00
  • KORE $282,254,000.00
  • Revenue This Year
  • RLYB N/A
  • KORE $4.66
  • Revenue Next Year
  • RLYB N/A
  • KORE $6.71
  • P/E Ratio
  • RLYB N/A
  • KORE N/A
  • Revenue Growth
  • RLYB N/A
  • KORE N/A
  • 52 Week Low
  • RLYB $0.22
  • KORE $1.10
  • 52 Week High
  • RLYB $1.54
  • KORE $4.88
  • Technical
  • Relative Strength Index (RSI)
  • RLYB 48.81
  • KORE 45.18
  • Support Level
  • RLYB $0.32
  • KORE $2.23
  • Resistance Level
  • RLYB $0.37
  • KORE $2.48
  • Average True Range (ATR)
  • RLYB 0.03
  • KORE 0.20
  • MACD
  • RLYB -0.00
  • KORE -0.01
  • Stochastic Oscillator
  • RLYB 41.25
  • KORE 57.45

About RLYB Rallybio Corporation

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders. The programs of the company are for the prevention of fetal and neonatal alloimmune thrombocytopenia, a potentially life-threatening rare disease that can cause uncontrolled bleeding in fetuses and newborns.

About KORE KORE Group Holdings Inc.

Kore Group Holdings Inc provides Internet of Things (IoT) solutions and services. In addition to providing critical services to customers globally, it enables them to manage, deploy, and scale their IoT applications and use cases. It offers connectivity services, location-based services, device solutions, and managed and professional services for the development and support of IoT technology for the Machine-to-Machine market. It derives revenue from IoT Connectivity services, IoT Solutions services, SIMs (IoT Connectivity), and IoT devices (IoT Solutions). Geographically, the company generates the majority of its revenue from the United States and the rest from other countries.

Share on Social Networks: